人福医药：奥卡西平缓释片获美国FDA暂定批准文号

Group 1 - The company, Renfu Pharmaceutical, announced that its subsidiary, Wuhan Renfulikang Pharmaceutical Co., Ltd., received a tentative approval number from the U.S. Food and Drug Administration (FDA) for Oxcarbazepine extended-release tablets [1] - The Oxcarbazepine extended-release tablets are indicated for the treatment of partial seizures in patients aged 6 years and older [1]